Basford C, Forraz N, Habibollah S, Hanger K, McGuckin C P
Newcastle Centre for Cord Blood, Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK.
Cell Prolif. 2009 Dec;42(6):751-61. doi: 10.1111/j.1365-2184.2009.00646.x. Epub 2009 Sep 15.
Currently the most frequently used method for umbilical cord blood separation in many hospitals across the UK and the rest of the world, where small-to-medium amounts of samples are processed, is Hetastarch, a mechanical, starch-based method, which causes red cell agglutination by rouleaux formation.
In this study, a novel method (Prepa-Cyte-CB), in comparison with Hetastarch as part of an FDA-approved clinical study, was evaluated.
Validation of data included recovery of nucleated and CD34+ cells, red blood cell reduction, colony forming unit potential, flow cytometric analysis and sterility tests.
PrepaCyte-CB, in comparison with Hetastarch offers fast, reliable separation with improved recovery of nucleated cells, 72.03% (+/-8.48 SD) compared to 58.09% (+/-20.06 SD), and CD34+ haematopoietic progenitor cells, 76% (+/-19.54 SD) compared to 64.19% (+/-29.77 SD). PrepaCyte-CB was also 12-fold more efficient in removing red blood cells and haemoglobin (P < 0.001) than Hetastarch.
These results show that PrepaCyte-CB offers superior separation of UCB when compared to Hetastarch.
目前,在英国及世界其他地区的许多医院中,当处理中小量样本时,最常用的脐血分离方法是羟乙基淀粉法,这是一种基于淀粉的机械方法,通过红细胞缗钱状形成导致红细胞凝集。
在本研究中,作为美国食品药品监督管理局(FDA)批准的一项临床研究的一部分,对一种新方法(Prepa-Cyte-CB)与羟乙基淀粉法进行了比较评估。
数据验证包括有核细胞和CD34+细胞的回收率、红细胞减少情况、集落形成单位潜力、流式细胞术分析和无菌测试。
与羟乙基淀粉法相比,PrepaCyte-CB能实现快速、可靠的分离,有核细胞回收率更高,分别为72.03%(±8.48标准差)和58.09%(±20.06标准差),CD34+造血祖细胞回收率分别为76%(±19.54标准差)和64.19%(±29.77标准差)。PrepaCyte-CB去除红细胞和血红蛋白的效率也比羟乙基淀粉法高12倍(P < 0.001)。
这些结果表明,与羟乙基淀粉法相比,PrepaCyte-CB在脐血分离方面表现更优。